Introduction
============

Corneoscleral melt is a severe ocular condition characterized by progressive tissue thinning often leading to perforation. It may be initiated by a wide variety of underlying factors, most commonly systemic or local autoimmune disease, microbial infection or previous surgery. Anterior segment ischemia following recti muscle surgery and alkali burns has also been implicated. Carotid artery stenosis may cause ocular ischemia either of embolic nature or due to chronic hypoperfusion. One case of ischemic scleral melt due to carotid artery obstruction has been reported ([@b9-co-2-649]), but to our knowledge no such case of conjunctival-corneal melt has been previously described.

Case report
===========

A 76-year-old man with a history of left nonarteritic ischemic optic neuropathy, presented with irritation in the same eye. A perilimbal area of conjunctival thinning with surrounding injection and central epithelial defect was noted temporally. The eye was otherwise quiet with no corneal edema, anterior chamber activity or clinically apparent iris atrophy. Microbiology and virology testing were negative. He did not exhibit any clinical features of systemic vasculitis (including giant cell arteritis) or autoimmune disease. Full blood count and inflammatory markers were within normal ranges (ESR 16, CRP \<5). Autoimmune screen (RF, nuclear mitochondrial and smooth muscle ANA, pANCA, cANCA, dsDNA screen, ENA screen, C3 and 4 complement, and cryoglobulins) was negative. Despite the use of intensive antibiotics, bandage contact lenses (22/9.2 mm plano, 72% water content), punctal plugs, lubricants and topical steroids, the defect gradually increased in size ([Figure 1](#f1-co-2-649){ref-type="fig"}). All investigations were repeated and normal. Multiple attempts to surgically close the defect led only to rapid recurrence, and an amniotic membrane patch graft to aid conjunctival healing dissolved within two days. Biopsies on three separate occasions showed moderate chronic inflammatory cell infiltrate with no evidence of neoplasia. Despite regular follow-up and intensive lubrication he developed adjacent corneal thinning and subsequent perforation. This was successfully glued and the eye settled somewhat albeit with a large persistent conjunctival defect ([Figure 2](#f2-co-2-649){ref-type="fig"}).

Our patient was known to have severe carotid artery stenosis (right \>90%, left totally occluded) causing symptomatic transient ischemic attacks, but endarterectomy was declined due to significant anesthetic risks. Doppler scanning confirmed reduced flow bilaterally in the common carotid arteries, absent flow of the left internal carotid artery, a tight stenosis with peak systolic velocity of 400 cm/second in the right internal carotid artery, and reversed flow in the left supratrochlear artery. Anterior segment fluorescein angiography showed marked delay in antecubital-episcleral perfusion times to both eyes: right 38, left (affected eye) 52 seconds. He had widespread severe cardiovascular disease, suffered increasing transient ischemic attacks and unfortunately died soon afterwards from myocardial infarction.

Discussion
==========

Anterior segment ischemia may cause corneoscleral melt, being well documented following chemical injuries and recti surgery. It has also been incidentally described in conjunction with eyelid necrosis following retrobulbar anesthesia (3 ml of lidocaine 2% with epinephrine \[1:10,000\]) ([@b11-co-2-649]). [@b9-co-2-649] recently reported the case of a 71 year-old man with progressive scleral melting and two failed conjunctival grafts, in which the only risk factor found was significant carotid stenosis. Normal carotid Doppler flow was demonstrated following endarterectomy, after which the ocular situation stabilized.

This case was extensively negatively-investigated, and melting progressed despite intensive lubrication, antibiotics, and surgical intervention. He had an extensive history of vascular disease with severe carotid artery stenosis; the left, ipsilateral to both the nonarteritic ischemic optic neuropathy and conjunctival-corneal melt, being totally occluded. Antecubital-episcleral perfusion times were markedly delayed on fluorescein angiography (normal 8--23 seconds depending on height \[[@b8-co-2-649]\]), again, more so to the left. In the absence of other risk factors for conjunctival-corneal melt this cannot be ignored.

Occlusive carotid artery disease may produce acute ophthalmic manifestations due to embolism, or chronic manifestations associated with progressive ocular ischemia. Chronic ischemia produces ocular ischemic syndrome, characterised by venous dilatation, midperipheral intraretinal hemorrhages, macular edema, neovascularisation, cataract, and aqueous flare. Although our case demonstrated no features of classic ocular ischemic syndrome, these findings are by no means universal with severe carotid stenosis ([@b4-co-2-649]). There was however evidence of nonarteritic anterior ischemic optic neuropathy in the same eye. The latter appears to result from perfusion insufficiency in the short posterior ciliary arteries leading to infarction of the retrolaminar portion of the optic disc ([@b7-co-2-649]), and has been associated with ocular ischemic syndrome as a complication of carotid artery occlusion ([@b1-co-2-649]). Similarly chronic hypoperfusion of the anterior ciliary/episcleral arteries may result in localized/focal anterior segment ischemia and subsequent melting.

Neovascularisation is an inhibitor of corneal ulceration ([@b3-co-2-649]) possibly through the provision of inhibitors of the matrix metalloproteinases (MMPs) ([@b6-co-2-649]). It is possible therefore, that in this case, the ischemia led to a relative deficiency of MMP inhibitors, with subsequent destruction of the reparative process. In addition, stimulated phagocytic cells not only produce active oxygen species during the respiratory burst, but also release neutral collagenase and acid lysosomal hydrolases that contribute to and amplify the degradation of the extracellular matrix ([@b2-co-2-649]). It has been shown in skin that ischemia and hypoxia result in elevated collagen remodeling in an oxygen-poor environment, and that unstable collagen molecules are synthesized together with upregulated MMPs, resulting in collagen denaturation, defective angiogenesis, weaker skin, and predisposition to ulceration ([@b5-co-2-649]). A similar mechanism may therefore occur in the conjunctiva. In a rabbit model, oxygen therapy has been shown to reduce corneal ulceration ([@b10-co-2-649]). Ocular ischemia should therefore be considered as a causative or contributing factor to melting and ulceration of the ocular surface.
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